Engulfing tumors with synthetic extracellular matrices for cancer immunotherapy
- 19 September 2009
- journal article
- Published by Elsevier BV in Biomaterials
- Vol. 30 (35), 6757-6767
- https://doi.org/10.1016/j.biomaterials.2009.08.037
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation (0348259)
- National Institutes of Health (EB007280, U54-CA112967, U54-CA126515)
- Defense Advanced Research Projects Agency (W81XWH-04-C-0139)
This publication has 47 references indexed in Scilit:
- Infection-mimicking materials to program dendritic cells in situNature Materials, 2009
- Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factorsActa Biomaterialia, 2008
- Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanomaThe Journal of Experimental Medicine, 2008
- Interleukin-15/Interleukin-15Rα Complexes Promote Destruction of Established Tumors by Reviving Tumor-Resident CD8+ T CellsCancer Research, 2008
- Pathways Mediating the Expansion and Immunosuppressive Activity of Myeloid-Derived Suppressor Cells and Their Relevance to Cancer TherapyClinical Cancer Research, 2007
- Mechanism and Therapeutic Reversal of Immune Suppression in CancerCancer Research, 2007
- DC-based cancer vaccinesJCI Insight, 2007
- CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cellsJCI Insight, 2006
- Converting IL-15 to a superagonist by binding to soluble IL-15RαProceedings of the National Academy of Sciences, 2006
- Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastasesEuropean Journal of Surgical Oncology, 2005